MADHAVBAUG — Vaidya Sane Ayurved Laboratories Balance Sheet
0.000.00%
- IN₹1.47bn
- IN₹1.28bn
- IN₹993.31m
- 82
- 27
- 44
- 52
Annual balance sheet for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10.6 | 9.05 | 192 | 156 | 194 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30.5 | 32.3 | 45.3 | 71.2 | 84.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 85 | 71.9 | 255 | 278 | 335 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 182 | 171 | 172 | 201 | 237 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 291 | 258 | 500 | 549 | 709 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 187 | 139 | 125 | 129 | 139 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 209 | 160 | 141 | 144 | 153 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 82.2 | 97.7 | 359 | 405 | 556 |
Total Liabilities & Shareholders' Equity | 291 | 258 | 500 | 549 | 709 |
Total Common Shares Outstanding |